NO20043152L - Doseringsform med en tablettkjerne av aktiv bestanddel innesluttet i et sammenpresset, ringformet legeme av pulver eller granulaert materiale, samt fremgangsmate og utstyr for fremstilling derav - Google Patents
Doseringsform med en tablettkjerne av aktiv bestanddel innesluttet i et sammenpresset, ringformet legeme av pulver eller granulaert materiale, samt fremgangsmate og utstyr for fremstilling deravInfo
- Publication number
- NO20043152L NO20043152L NO20043152A NO20043152A NO20043152L NO 20043152 L NO20043152 L NO 20043152L NO 20043152 A NO20043152 A NO 20043152A NO 20043152 A NO20043152 A NO 20043152A NO 20043152 L NO20043152 L NO 20043152L
- Authority
- NO
- Norway
- Prior art keywords
- compressed
- powder
- preparation
- equipment
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/005—Coating of tablets or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34244201P | 2001-12-24 | 2001-12-24 | |
US36182102P | 2002-03-04 | 2002-03-04 | |
PCT/US2002/036081 WO2003057136A2 (en) | 2001-12-24 | 2002-11-12 | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20043152L true NO20043152L (no) | 2004-09-02 |
Family
ID=26993007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20043152A NO20043152L (no) | 2001-12-24 | 2004-07-23 | Doseringsform med en tablettkjerne av aktiv bestanddel innesluttet i et sammenpresset, ringformet legeme av pulver eller granulaert materiale, samt fremgangsmate og utstyr for fremstilling derav |
Country Status (14)
Country | Link |
---|---|
US (2) | US7611722B2 (de) |
EP (2) | EP1465606A4 (de) |
JP (1) | JP4414228B2 (de) |
KR (1) | KR100897837B1 (de) |
CN (1) | CN1620284B (de) |
BR (1) | BR0215413A (de) |
CA (1) | CA2470495A1 (de) |
EA (1) | EA006053B1 (de) |
HU (1) | HUP0600680A3 (de) |
IL (1) | IL162459A0 (de) |
MX (1) | MXPA04006310A (de) |
NO (1) | NO20043152L (de) |
NZ (3) | NZ552513A (de) |
WO (1) | WO2003057136A2 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
CN1620284B (zh) | 2001-12-24 | 2010-04-28 | 特瓦制药工业有限公司 | 含有用粉末或粒状材料的压缩环状体包鞘的有效成分片芯的剂型,及其生产工艺和工具 |
IL163887A0 (en) * | 2002-03-04 | 2005-12-18 | Teva Pharma | Controlled release dosage forms |
CN1738600A (zh) * | 2002-11-12 | 2006-02-22 | 特瓦制药工业有限公司 | 用于口腔给药和舌下给药的替扎尼定药物组合物及剂型以及舌下或口腔给予替扎尼定的方法 |
MXPA06004327A (es) * | 2003-10-20 | 2007-01-26 | Teva Pharma | Composiciones y forma de dosificacion para el efecto retardado de levodopa. |
CA2555406A1 (en) * | 2004-02-19 | 2005-09-01 | Teva Pharmaceutical Industries, Ltd. | Improved therapy using a combination of raloxifene and alendronate |
US20060002986A1 (en) * | 2004-06-09 | 2006-01-05 | Smithkline Beecham Corporation | Pharmaceutical product |
AU2011204852B2 (en) * | 2004-06-09 | 2013-01-10 | Glaxosmithkline Llc | Apparatus and method for pharmaceutical production |
TWI356036B (en) * | 2004-06-09 | 2012-01-11 | Smithkline Beecham Corp | Apparatus and method for pharmaceutical production |
CA2575006A1 (en) * | 2004-07-26 | 2006-02-02 | E. Itzhak Lerner | Dosage forms with an enterically coated core tablet |
JP2008507587A (ja) * | 2004-07-26 | 2008-03-13 | テバ ファーマシューティカル インダストリーズ リミティド | 腸溶性被覆されたコアー錠剤を有する投与形 |
US20060018957A1 (en) * | 2004-07-26 | 2006-01-26 | Lerner E I | Pharmaceutical dosage forms including rasagiline |
US20060024368A1 (en) * | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
DK1836665T3 (da) * | 2004-11-19 | 2013-04-15 | Glaxosmithkline Llc | Fremgangsmåde til specialtilpasset afgivelse af medikamentkombinationsprodukter med variabel dosis til individualisering af terapier |
US20070003621A1 (en) * | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Dosage forms for movement disorder treatment |
WO2007056570A2 (en) * | 2005-11-07 | 2007-05-18 | Teva Pharmaceutical Industries Ltd. | Levodopa compositions |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
US8765178B2 (en) * | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
US9744137B2 (en) | 2006-08-31 | 2017-08-29 | Supernus Pharmaceuticals, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
AU2007319141B2 (en) | 2006-11-17 | 2013-01-10 | Supernus Pharmaceuticals Inc. | Sustained-release formulations of topiramate |
AU2007338631A1 (en) * | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
GB0702974D0 (en) * | 2007-02-15 | 2007-03-28 | Jagotec Ag | Method and apparatus for producing a tablet |
US20130059062A1 (en) * | 2010-03-11 | 2013-03-07 | Ramakant Kashinath Gundu | Device For The Manufacture Of A Dosage Form With A Hole And Method Of Manufacture |
CN103370058A (zh) | 2010-12-22 | 2013-10-23 | 普渡制药公司 | 包覆的抗篡改控制释放剂型 |
CA2822769C (en) | 2010-12-23 | 2016-10-04 | Purdue Pharma L.P. | Tamper resistant solid oral dosage forms |
WO2012129237A2 (en) | 2011-03-20 | 2012-09-27 | Trustees Of Boston University | Therapeutic agent for emphysema and copd |
WO2013003697A1 (en) | 2011-06-30 | 2013-01-03 | Trustees Of Boston University | Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
KR101840526B1 (ko) | 2013-02-05 | 2018-03-20 | 퍼듀 퍼머 엘피 | 내변조성 제약 제제 |
US10751287B2 (en) | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
JP6296371B2 (ja) * | 2013-12-23 | 2018-03-20 | ウェン、シャオガンWEN, Xiaoguang | 二層錠剤の調製方法 |
FR3021666B1 (fr) * | 2014-05-28 | 2017-12-08 | Eurotab | Tablette multicouches a cavite, dispositif et procede de compaction d'une telle tablette |
EP3302442A4 (de) | 2015-06-03 | 2019-02-06 | Triastek, Inc. | Darreichungsform und verwendung davon |
US10844154B2 (en) | 2015-11-20 | 2020-11-24 | Isp Investments Llc | Proliferous copolymers comprising lactamic moieties |
US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
WO2018213600A1 (en) * | 2017-05-17 | 2018-11-22 | Massachusetts Institute Of Technology | Self-righting systems and related components and methods |
US11571391B2 (en) | 2018-01-09 | 2023-02-07 | Triastek, Inc. | Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant |
US11877576B2 (en) * | 2018-06-22 | 2024-01-23 | Ideaz, Llc | Diphenyl tablets and methods of preparing the same |
CN113463047A (zh) * | 2021-08-18 | 2021-10-01 | 广东先导稀材股份有限公司 | 一种靶材制备电动辅助装置 |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US508915A (en) * | 1893-11-21 | Wabhinqton | ||
US36475A (en) * | 1862-09-16 | Improvement in machines for making horseshoes | ||
US1609460A (en) * | 1925-01-28 | 1926-12-07 | Western Electric Co | Apparatus for molding articles under high pressure |
US1806300A (en) * | 1930-02-01 | 1931-05-19 | Moraine Products Company | Briquetting machine |
US2027915A (en) * | 1933-01-27 | 1936-01-14 | Albert S Kux | Compressing machine |
US2573365A (en) * | 1947-10-04 | 1951-10-30 | Sylvania Electric Prod | Apparatus for fabricating insulating members for lamp bases and the like |
GB972128A (en) | 1960-01-21 | 1964-10-07 | Wellcome Found | Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets |
US3149375A (en) * | 1961-08-18 | 1964-09-22 | Corning Glass Works | Apparatus and method for molding cup-shaped bodies |
US3353215A (en) * | 1965-11-10 | 1967-11-21 | Haller John | Powdered material briquetting press |
US3593366A (en) * | 1968-12-11 | 1971-07-20 | Wolverine Pentronix | Multiple punch tool set for powder compacting press |
GB1242259A (en) * | 1968-12-13 | 1971-08-11 | Birmingham Small Arms Co Ltd | Improvements in or relating to compacting machines |
US3995631A (en) | 1971-01-13 | 1976-12-07 | Alza Corporation | Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient |
US3977404A (en) | 1975-09-08 | 1976-08-31 | Alza Corporation | Osmotic device having microporous reservoir |
US4061453A (en) | 1975-10-06 | 1977-12-06 | Wolverine Aluminum Corporation | Tooling for a powder compacting press |
DE2604648C2 (de) * | 1976-02-04 | 1980-10-09 | Emil Korsch Spezialfabrik Fuer Komprimiermaschinen, 1000 Berlin | Rundlaufpresse |
JPS5746986A (en) | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
US4352648A (en) * | 1980-12-22 | 1982-10-05 | Toolmakers, Incorporated | Powdered metal press and tooling therefor |
US4443171A (en) * | 1982-04-14 | 1984-04-17 | Wesjay, Inc. | Multi-motion mechanical press |
US4639338A (en) | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
GB8514666D0 (en) * | 1985-06-11 | 1985-07-10 | Coopers Animal Health | Agent delivery systems |
NO166131C (no) | 1985-06-20 | 1991-06-05 | Daiichi Seiyaku Co | Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser. |
IT1188212B (it) | 1985-12-20 | 1988-01-07 | Paolo Colombo | Sistema per il rilascio a velocita' controllata di sostanze attive |
US5088915A (en) * | 1988-06-08 | 1992-02-18 | Korsch Ohg Maschinenfabrik | Coated-core press |
IT1237904B (it) | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
US5071607A (en) | 1990-01-31 | 1991-12-10 | Alza Corporatino | Method and apparatus for forming a hole in a drug dispensing device |
KR920003605B1 (ko) | 1990-03-27 | 1992-05-04 | 한국과학기술연구원 | 피페라지닐 퀴놀론 유도체의 제조방법 |
DE4019023A1 (de) | 1990-06-14 | 1991-12-19 | Bayer Ag | Verfahren zur herstellung von chinolincarbonsaeuren |
DE4025484C1 (de) | 1990-08-08 | 1991-10-10 | Korsch Maschfab | |
JPH07115233B2 (ja) * | 1990-08-10 | 1995-12-13 | 株式会社ヨシツカ精機 | 粉末成形プレス |
US5234646A (en) | 1990-08-30 | 1993-08-10 | Shionogi & Co., Ltd. | Method for molding powder under compression |
US5156850A (en) | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
ES2106818T3 (es) | 1991-10-30 | 1997-11-16 | Glaxo Group Ltd | Composicion multicapa que contiene antagonistas de histamina o secotina. |
US5277570A (en) | 1992-03-30 | 1994-01-11 | Siggers David L | Press for pressing a compressible material |
JPH0798279B2 (ja) | 1992-11-05 | 1995-10-25 | 株式会社ヨシツカ精機 | 粉末成形プレスのパンチ接続方法および接続装置 |
US6406714B1 (en) | 1992-12-02 | 2002-06-18 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids |
US5358941A (en) | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
JP3345133B2 (ja) | 1992-12-21 | 2002-11-18 | サンスター株式会社 | 練歯磨組成物 |
US6399592B1 (en) | 1992-12-23 | 2002-06-04 | Merck & Co., Inc. | Bishphosphonate/estrogen synergistic therapy for treating and preventing bone loss |
WO1994014455A1 (en) | 1992-12-23 | 1994-07-07 | Merck & Co., Inc. | Bisphosphonate/estrogen therapy for treating and preventing bone loss |
DE9306785U1 (de) | 1993-05-05 | 1993-07-08 | Kilian & Co. GmbH Maschinenfabrik, 5000 Köln | Rundlauf-Tablettenpresse |
US5653926A (en) | 1993-09-10 | 1997-08-05 | Fuisz Technologies, Ltd. | Method and apparatus for forming compression dosage units |
US5431920A (en) | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
JP3585495B2 (ja) * | 1993-11-24 | 2004-11-04 | スタックポール リミテッド | 位相がずらされた割り形ダイ |
DE4401358C2 (de) | 1994-01-15 | 1995-11-23 | Korsch Pressen Gmbh | Vorrichtung zum Befestigen der Matrizen im Matrizentisch einer Rundlauf-Tablettiermaschine |
KR0125115B1 (ko) | 1994-03-22 | 1997-12-05 | 김은영 | (-)피페라진 벤즈옥사진 유도체의 제조방법 |
DE9409108U1 (de) | 1994-06-03 | 1994-08-04 | Wilhelm Fette Gmbh, 21493 Schwarzenbek | Preßstempel für eine Tablettiermaschine |
US5672364A (en) | 1994-07-07 | 1997-09-30 | Sankyo Seisakusho Co. & Eisai Co., Ltd. | Apparatus for manufacturing tablets |
DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
US20010051616A1 (en) | 1995-02-17 | 2001-12-13 | David B. Karpf | Method of lessening the risk of vertebral fractures |
KR19980702210A (ko) | 1995-02-17 | 1998-07-15 | 폴락 돈나 엘 | 비척추골 골절의 위험률을 감소시키는 방법 |
TW287975B (en) | 1995-11-16 | 1996-10-11 | Honda Motor Co Ltd | Method of and apparatus for manufacturing pressed powder body |
DE29520473U1 (de) | 1995-12-22 | 1996-03-28 | Koch, Rudolf, 83646 Bad Tölz | Vorrichtung zur Herstellung von Tabletten |
US6620358B2 (en) * | 1996-07-03 | 2003-09-16 | Gunter Voss | Process for manufacturing tablets |
JP4098376B2 (ja) | 1996-09-05 | 2008-06-11 | ビーエーエスエフ ソシエタス・ヨーロピア | 錠剤特性の優れた水溶性ビタミン組成物およびその製造法 |
US5994377A (en) | 1996-10-21 | 1999-11-30 | Gilead Sciences, Inc. | Piperidine compounds |
DK0946151T3 (da) | 1996-11-25 | 2006-08-28 | Alza Corp | Doseringsform med stigende dosisfrigivelse |
CA2197267C (en) | 1997-02-11 | 2000-02-08 | Yong Tao | Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
KR100400053B1 (ko) | 1997-06-11 | 2003-09-29 | 더 프록터 앤드 갬블 캄파니 | 향상된 상부 위장관 안전용 필름 피복 정제 |
US5994329A (en) | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6015801A (en) | 1997-07-22 | 2000-01-18 | Merck & Co., Inc. | Method for inhibiting bone resorption |
IL121623A (en) | 1997-08-26 | 2000-06-29 | Unipharm Ltd | Process for the preparation of solid oral dosage forms comprising alendronic acid |
US20010046977A1 (en) | 1997-11-25 | 2001-11-29 | Merck & Co., Inc. | Use of alendronate for the prevention of osteoporosis |
EP1088333A4 (de) | 1998-06-24 | 2005-08-10 | Merck & Co Inc | Verfahren und zussamensetzungen zur verbindung von osteoprose |
KR20000011247A (ko) | 1998-07-23 | 2000-02-25 | 김윤 | 다당류를이용한대장선택성약물전달조성물및약학제제 |
US6008207A (en) | 1998-08-13 | 1999-12-28 | Merck & Co., Inc. | Anhydrous alendronate monosodium salt formulations |
WO2000012517A1 (en) * | 1998-08-27 | 2000-03-09 | Teva Pharmaceutical Industries Ltd. | Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
EP0998932A1 (de) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
US6414006B1 (en) | 1998-10-15 | 2002-07-02 | Merck Frosst Canada & Co. | Methods for inhibiting bone resorption |
US6416737B1 (en) | 1998-11-19 | 2002-07-09 | Board Of Trustees Of The University Of Arkansas | Increasing bone strength with selected bisphosphonates |
KR100665633B1 (ko) | 1999-02-17 | 2007-01-10 | 테바 파마슈티컬 인더스트리즈 리미티드 | 알렌드론산을 제조하는 신규한 방법 |
CA2376077A1 (en) | 1999-06-23 | 2000-12-28 | Merck & Co., Inc. | Integrin receptor antagonists |
AR024462A1 (es) | 1999-07-01 | 2002-10-02 | Merck & Co Inc | Tabletas farmaceuticas |
US6963008B2 (en) | 1999-07-19 | 2005-11-08 | Teva Pharmaceutical Industries Ltd. | Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
ES2153794B1 (es) | 1999-08-06 | 2001-10-16 | Medichem Sa | Procedimiento para la obtencion del acido 4-amino-1-hidroxibutiliden-1,1-bisfosfonico y de su sal monosodica trihidratada. |
AU7743400A (en) | 1999-10-04 | 2001-05-10 | Merck & Co., Inc. | Integrin receptor antagonists |
PE20011065A1 (es) | 2000-02-01 | 2001-11-21 | Procter & Gamble | Proceso para fabricar bisfosfonatos geminales |
US20020151459A1 (en) | 2000-02-25 | 2002-10-17 | Merck & Co., Inc. | Methods for identifying compounds useful for inhibiting farnesyl diphosphate synthase |
US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
KR100463775B1 (ko) * | 2000-12-04 | 2004-12-29 | 가부시키가이샤 무라타 세이사쿠쇼 | 분말 공급 장치 및 분말 성형 장치 |
DE10114868C1 (de) | 2001-03-26 | 2002-10-31 | Oxeno Olefinchemie Gmbh | Verfahren zur Herstellung von Diphosphinen und deren Verwendung |
TR200101250A2 (tr) | 2001-05-10 | 2003-04-21 | E�S Eczaciba�I �Zg�N K�Myasal �R�Nler Sanay� A.�. | 4-amino-1-hidroksibutiliden-1,1-bifosfonik asit veya tuzlarının hazırlanmasına ilişkin proses |
EP1416919A1 (de) | 2001-07-17 | 2004-05-12 | Teva Pharmaceutical Industries Ltd. | Dosierformen für die unmittelbare gastrische freisetzung eines calcium-transport-stimulators in verbindung mit der verzögerten gastrischen freisetzung eines bis-phosphonats |
US6645974B2 (en) | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
GB2383042A (en) | 2001-10-18 | 2003-06-18 | Cipla Ltd | Amorphous alendronate sodium |
US6863901B2 (en) | 2001-11-30 | 2005-03-08 | Collegium Pharmaceutical, Inc. | Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
CN1620284B (zh) | 2001-12-24 | 2010-04-28 | 特瓦制药工业有限公司 | 含有用粉末或粒状材料的压缩环状体包鞘的有效成分片芯的剂型,及其生产工艺和工具 |
ITMI20020146A1 (it) | 2002-01-29 | 2003-07-29 | Lyogen Ltd | Alendronato monosodico amorfo e processo per la sua preparazione |
DE10216997A1 (de) | 2002-04-16 | 2003-10-30 | Merck Patent Gmbh | Verfahren zur Herstellung von Bis(perfluoralkyl)phosphinsäuren und deren Salze |
ITMI20020908A1 (it) | 2002-04-29 | 2003-10-29 | Chemi Spa | Processo di preparazione di sodio alendronato |
JP3857706B2 (ja) | 2002-05-17 | 2006-12-13 | テバ ファーマシューティカル インダストリーズ リミティド | ビスホスホン酸作製のための特定の希釈剤の使用 |
US20050026871A1 (en) | 2002-07-17 | 2005-02-03 | Moshe Flashner-Barak | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative |
WO2005035542A1 (en) | 2003-10-14 | 2005-04-21 | Pliva-Istrazivanje I Razvoj D.O.O. | Solid-state form of alendronate sodium and preparation thereof |
DE10350676A1 (de) | 2003-10-30 | 2005-06-02 | Basf Ag | Verfahren zur Herstellung eines Alkenylphosphonsäure-Derivats |
US20050181043A1 (en) | 2004-02-12 | 2005-08-18 | Indranil Nandi | Alendronate salt tablet compositions |
-
2002
- 2002-11-12 CN CN028282361A patent/CN1620284B/zh not_active Expired - Fee Related
- 2002-11-12 JP JP2003557495A patent/JP4414228B2/ja not_active Expired - Fee Related
- 2002-11-12 HU HU0600680A patent/HUP0600680A3/hu unknown
- 2002-11-12 EA EA200400862A patent/EA006053B1/ru not_active IP Right Cessation
- 2002-11-12 KR KR1020047010037A patent/KR100897837B1/ko not_active IP Right Cessation
- 2002-11-12 NZ NZ552513A patent/NZ552513A/en not_active IP Right Cessation
- 2002-11-12 IL IL16245902A patent/IL162459A0/xx unknown
- 2002-11-12 EP EP02789567A patent/EP1465606A4/de not_active Withdrawn
- 2002-11-12 NZ NZ552514A patent/NZ552514A/en not_active IP Right Cessation
- 2002-11-12 NZ NZ534104A patent/NZ534104A/en not_active IP Right Cessation
- 2002-11-12 MX MXPA04006310A patent/MXPA04006310A/es not_active Application Discontinuation
- 2002-11-12 CA CA002470495A patent/CA2470495A1/en not_active Abandoned
- 2002-11-12 EP EP09180574A patent/EP2172192A1/de not_active Withdrawn
- 2002-11-12 BR BR0215413-7A patent/BR0215413A/pt not_active IP Right Cessation
- 2002-11-12 WO PCT/US2002/036081 patent/WO2003057136A2/en active IP Right Grant
-
2003
- 2003-04-21 US US10/419,536 patent/US7611722B2/en not_active Expired - Fee Related
-
2004
- 2004-07-23 NO NO20043152A patent/NO20043152L/no not_active Application Discontinuation
- 2004-10-29 US US10/978,246 patent/US20050112202A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA04006310A (es) | 2005-04-19 |
KR20040073512A (ko) | 2004-08-19 |
KR100897837B1 (ko) | 2009-05-15 |
US20050112202A1 (en) | 2005-05-26 |
NZ534104A (en) | 2007-03-30 |
EA200400862A1 (ru) | 2004-12-30 |
HUP0600680A3 (en) | 2008-04-28 |
JP2005517678A (ja) | 2005-06-16 |
JP4414228B2 (ja) | 2010-02-10 |
AU2002352613A1 (en) | 2003-07-24 |
EP1465606A2 (de) | 2004-10-13 |
EP2172192A1 (de) | 2010-04-07 |
BR0215413A (pt) | 2004-12-14 |
NZ552514A (en) | 2008-08-29 |
WO2003057136A2 (en) | 2003-07-17 |
HUP0600680A2 (en) | 2007-02-28 |
NZ552513A (en) | 2008-08-29 |
WO2003057136A3 (en) | 2004-02-12 |
EP1465606A4 (de) | 2009-04-22 |
EA006053B1 (ru) | 2005-08-25 |
CN1620284B (zh) | 2010-04-28 |
US20030206954A1 (en) | 2003-11-06 |
CN1620284A (zh) | 2005-05-25 |
CA2470495A1 (en) | 2003-07-17 |
IL162459A0 (en) | 2005-11-20 |
US7611722B2 (en) | 2009-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20043152L (no) | Doseringsform med en tablettkjerne av aktiv bestanddel innesluttet i et sammenpresset, ringformet legeme av pulver eller granulaert materiale, samt fremgangsmate og utstyr for fremstilling derav | |
ITMI20010005A0 (it) | Dispositivo per dosare ed introdurre polvere in capsule di gelatina rigida o simili | |
CA2451842A1 (en) | Chewable product including active ingredient | |
NO983832D0 (no) | Medikamentinhalator med pulver | |
WO2004056337A3 (en) | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats | |
NO307864B1 (no) | Farmasøytisk aerosolformulering, boks og doseringsinhalator | |
AU2003274681A1 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
HUP0101517A3 (en) | Formulation of fast-dissolving efavirenz capsules or tablets and process for the preparation thereof | |
NO20042367L (no) | Mikronisert filmdannende pulver omfattende et aktivt stoff | |
EP1242112A4 (de) | Partikel-enthaltende medikamente und methode zu deren herstellung | |
SG164281A1 (en) | Controlled release preparation | |
AU3076700A (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
MY135852A (en) | Pharmaceutical products | |
HUP1300117A2 (en) | Pharmaceutical formulations for dry powder inhalers in the form of hard pellets | |
SI1478339T1 (sl) | Farmacevtske formulacije antineoplastičnih sredstev, zlasti temozolomida, postopki za pripravo in uporabo le-teh | |
PT1306082E (pt) | Inaladores de dose calibrada pressurizada e formulacoes farmaceuticas de aerossol | |
AP9801173A0 (en) | Rapidly releasing and taste-making pharmaceutical dosage | |
HK1083749A1 (en) | Solid nano pharmaceutical formulation and preparation method thereof | |
NO841518L (no) | Delbare tabletter med forsinket frigjoering av virkestoff, og fremgangsmaate for fremstilling derav | |
MXPA00001924A (es) | Material de encapsulacion libre de gelatina flexible util para farmaceuticos, pelotas de pintura y otras formulaciones. | |
NO20010277L (no) | Benzocykloheptener, fremgangsmÕte for fremstilling derav, farmasøytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter | |
HUP0104687A2 (en) | Methods for preparing coated drug particles and pharmaceutical formulations thereof | |
WO2007028512A3 (de) | Magnetfeld-gesteuerter wirkstofftransfer für die aerosoltherapie | |
IL159217A0 (en) | An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine | |
IL146567A0 (en) | Oil-core particles containing a hydrophobic core material and hydrophobic drug and method for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |